Table 2.
Clinical and laboratory characteristics of the women at the time of enrollment.
| Characteristic | Values |
|---|---|
| N | 100 |
| Time since the index pregnancy (months) | 46 ± 26 |
| BMI (kg/m2) | 25.7 ± 5.8 |
| HbA1c (%) | 6.3 ± 1.5 |
| HOMA-%B | 105 ± 47 |
| HOMA-IR (median [range]) | 1.2 (0.4–4.0) |
| Normal glucose tolerance (%) | 19 |
| Abnormal glucose tolerance (%) | 81 |
| IFG | 0 |
| IGT | 38 |
| IGT + IFG | 5 |
| T2DM | 38 |
Data are presented as the mean ± standard deviation or percentage.
BMI: body mass index; HOMA-%B, homeostasis model assessment of β cell function; HOMA-IR: homeostasis model assessment of insulin resistance; IGT: impaired glucose tolerance; IFG: impaired fasting glucose; T2DM: type 2 diabetes mellitus.